These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Fibrinolytic responses to 1-desamino-8-D-arginine-vasopressin in patients with congenital nephrogenic diabetes insipidus. Knoers N; Brommer EJ; Willems H; van Oost BA; Monnens LA Nephron; 1990; 54(4):322-6. PubMed ID: 2109264 [TBL] [Abstract][Full Text] [Related]
6. [Polyuric dilatation of the urinary tract in congenital nephrogenic diabetes insipidus. Clinical and diagnostic aspects. Presentation of a case and review of the literature]. Soler Fernández JM; Caravaca Magariños F; Domínguez Bravo C; Murillo Mirat J; Herrera Puerto J; Sanz Cueva J Actas Urol Esp; 1990; 14(5):374-7. PubMed ID: 2288259 [TBL] [Abstract][Full Text] [Related]
8. Hemodynamic and coagulation responses to 1-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus. Bichet DG; Razi M; Lonergan M; Arthus MF; Papukna V; Kortas C; Barjon JN N Engl J Med; 1988 Apr; 318(14):881-7. PubMed ID: 2965301 [TBL] [Abstract][Full Text] [Related]
9. [Study of aldosterone metabolism in a case of congenital nephrogenic diabetes insipidus]. Godard C; Mégevand A; de Sousa RC; Muller AF Pediatr Res; 1968 Jan; 2(1):22-8. PubMed ID: 4295143 [No Abstract] [Full Text] [Related]
10. Hydrochlorothiazide-amiloride in the treatment of congenital nephrogenic diabetes insipidus. Alon U; Chan JC Am J Nephrol; 1985; 5(1):9-13. PubMed ID: 3970081 [TBL] [Abstract][Full Text] [Related]
11. Congenital nephrogenic diabetes insipidus-vasopressin and prostaglandins in response to treatment with hydrochlorothiazide and indomethacin. Rascher W; Rosendahl W; Henrichs IA; Maier R; Seyberth HW Pediatr Nephrol; 1987 Jul; 1(3):485-90. PubMed ID: 3153321 [TBL] [Abstract][Full Text] [Related]
13. Nephrogenic diabetes insipidus associated with bilateral ureteral obstruction. Kato A; Hishida A; Ishibashi R; Nakajima T; Ohura M; Furuya R; Kumagai H; Kimura M; Kaneko E Intern Med; 1994 Apr; 33(4):231-3. PubMed ID: 8069019 [TBL] [Abstract][Full Text] [Related]
14. Effect of hydrochlorothiazide and indomethacin treatment on renal function in nephrogenic diabetes insipidus. Jakobsson B; Berg U Acta Paediatr; 1994 May; 83(5):522-5. PubMed ID: 8086732 [TBL] [Abstract][Full Text] [Related]
15. Congenital nephrogenic diabetes insipidus. Report of a case. Zhang YM; Zhang XX; Li XL Chin Med J (Engl); 1985 Oct; 98(10):775-8. PubMed ID: 3938705 [No Abstract] [Full Text] [Related]
16. Indomethacin in the treatment of lithium-induced nephrogenic diabetes insipidus. Allen HM; Jackson RL; Winchester MD; Deck LV; Allon M Arch Intern Med; 1989 May; 149(5):1123-6. PubMed ID: 2719505 [TBL] [Abstract][Full Text] [Related]
17. Nephrogenic diabetes insipidus in a dog. Lage AL J Am Vet Med Assoc; 1973 Aug; 163(3):251-3. PubMed ID: 4721758 [No Abstract] [Full Text] [Related]
18. Cyclic adenosine monophosphate excretion in urine of patients and carriers of congenital nephrogenic diabetes insipidus. Uttley WS; Atkinson B; Adams A; Shirling D J Inherit Metab Dis; 1978; 1(2):75-7. PubMed ID: 229343 [TBL] [Abstract][Full Text] [Related]